Neurology Central, an online publication based in the United Kingdom, will sponsor a live webinar with MDI Biological Laboratory scientist James A. Coffman, Ph.D., on the subject of how chronic stress experienced during early development epigenetically programs adult disease risk.
Scientists have known for decades that drastically restricting certain nutrients without causing malnutrition prolongs health and lifespan in a wide range of species, but the molecular mechanisms underlying this effect have remained a mystery. In a paper recently published in the journal Aging Cell, MDI Biological Laboratory scientist Aric Rogers, Ph.D., sheds light on an important genetic pathway underlying this process, raising the possibility that therapies can be developed that can…
The MDI Biological Laboratory has announced that it has received a grant of $456,500 over two years from the National Institutes of Health (NIH) for the study of peripheral neuropathy.
Scientists at the MDI Biological Laboratory are identifying the basic mechanisms behind Parkinson’s disease, a degenerative neurological disease affecting millions of people worldwide. The research could some day lead to treatments for a disabling condition for which medicine now has nothing to offer other than symptomatic relief.
Recent research by Sandra Rieger, Ph.D., identifying the underlying mechanisms of peripheral neuropathy, or nerve damage, has raised the prospect that drug therapies can be developed for the treatment of this condition, which causes pain, numbness and/or tingling in the hands and feet. The research was published March 28 in the Proceedings of the National Academy of Sciences.
Research led by Sandra Rieger, Ph.D. has identified the mechanism behind chemo-induced peripheral neuropathy.